These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 809232)

  • 21. Loxapine concentrate in acute schizophrenia.
    O'Connell RA; Jeewa M; Allen K
    Curr Ther Res Clin Exp; 1977 Jan; 21(1):101-7. PubMed ID: 401704
    [No Abstract]   [Full Text] [Related]  

  • 22. [Clinical trial of loxapine succinate in the treatment of 30 cases of psychotic states].
    Escande M; Granier F; Gardes JP; Boscredon J; Concina M
    Ann Med Psychol (Paris); 1983 Mar; 141(3):309-22. PubMed ID: 6357022
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A double-blind comparison between loxapine and chlordiazepoxide in the treatment of neurotic anxiety.
    Versiani M; Bueno JR; Mundim FD; da Silva JA; Rocha AV
    Curr Ther Res Clin Exp; 1976 Nov; 20(5):701-15. PubMed ID: 825357
    [No Abstract]   [Full Text] [Related]  

  • 24. Loxapine succinate: a controlled double-blind study in schizophrenia.
    Charalampous KD; Freemesser GF; Malev J; Ford K
    Curr Ther Res Clin Exp; 1974 Aug; 16(8):829-37. PubMed ID: 4217251
    [No Abstract]   [Full Text] [Related]  

  • 25. A two year trial of loxapine succinate in chronic psychotic patients.
    Simpson GM; Branchey MH; Lee JH; Varga E
    Dis Nerv Syst; 1976 May; 37(5):305-7. PubMed ID: 816626
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A controlled double-blind comparison between loxapine and haloperidol in acute newly hospitalized schizophrenic patients.
    Paprocki J; Barcala Peixoto MP; Andrade NM
    Psychopharmacol Bull; 1976 Apr; 12(2):32-4. PubMed ID: 769026
    [No Abstract]   [Full Text] [Related]  

  • 27. Efficacy of loxapine in the treatment of paranoid schizophrenia.
    Bishop MP; Simpson GM; Dunnett CW; Kiltie H
    Psychopharmacology (Berl); 1977 Jan; 51(2):107-15. PubMed ID: 14350
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A double-blind comparative trial of loxapine and trifluoperazine in acute and chronic schizophrenic patients.
    Kiloh LG; Williams SE; Grant DA; Whetton PS
    J Int Med Res; 1976; 4(6):441-8. PubMed ID: 800384
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical pharmacological trial of loxapine succinate.
    J Clin Pharmacol J New Drugs; 1970; 10(3):175-81. PubMed ID: 4910276
    [No Abstract]   [Full Text] [Related]  

  • 30. A controlled evaluation of loxitane in seventy-five adolescent schizophrenic patients.
    Pool D; Bloom W; Mielke DH; Roniger JJ; Gallant DM
    Curr Ther Res Clin Exp; 1976 Jan; 19(1):99-104. PubMed ID: 812671
    [No Abstract]   [Full Text] [Related]  

  • 31. [Loxapine succinate: a new neuroleptic].
    Cottereau MJ; Poirier MF; Lôo H; Deniker P
    Encephale; 1979; 5(3):251-67. PubMed ID: 39739
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Loxapine succinate in the treatment of uncontrollable destructive behavior.
    Varga E; Simpson GM
    Curr Ther Res Clin Exp; 1971 Dec; 13(12):737-42. PubMed ID: 5001742
    [No Abstract]   [Full Text] [Related]  

  • 33. Loxapine as an alternative to phenothiazines in a case of oculocutaneous skin pigmentation.
    Ewing DG; Einarson TR
    Am J Psychiatry; 1981 Dec; 138(12):1631-2. PubMed ID: 7304801
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A comparison of parenteral loxapine and haloperidol in hostile and aggressive acutely schizophrenic patients.
    Tuason VB
    J Clin Psychiatry; 1986 Mar; 47(3):126-9. PubMed ID: 3512535
    [TBL] [Abstract][Full Text] [Related]  

  • 35. How effective is loxapine?
    Tuason VB; Escobar JI
    Am J Psychiatry; 1986 Jan; 143(1):116-7. PubMed ID: 3942265
    [No Abstract]   [Full Text] [Related]  

  • 36. A double-blind comparison of loxapine succinate and trifluoperazine in newly admitted schizophrenic patients.
    Simpson GM; Cuculic Z
    J Clin Pharmacol; 1976 Jan; 16(1):60-5. PubMed ID: 1107360
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antipsychotic properties of loxapine succinate.
    Gershon S; Hekimian LJ; Burdock EI; Kim SS
    Curr Ther Res Clin Exp; 1970 May; 12(5):280-5. PubMed ID: 4986243
    [No Abstract]   [Full Text] [Related]  

  • 38. Evaluation of two dose levels of loxapine succinate in chronic schizophrenia.
    Clark ML; Paredes A; Costiloe JP; Fulkerson FG; Wood F
    Dis Nerv Syst; 1977 Jan; 38(1):7-10. PubMed ID: 318984
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Loxapine update: 1966-1976.
    Ayd FJ
    Dis Nerv Syst; 1977 Nov; 38(11):883-7. PubMed ID: 410614
    [No Abstract]   [Full Text] [Related]  

  • 40. Evaluations of loxapine succinate in the ambulatory treatment of acute schizophrenic episodes.
    Zisook S; Click MA
    Int Pharmacopsychiatry; 1980; 15(6):365-78. PubMed ID: 7028656
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.